AI assistant
DAVITA INC. — Director's Dealing 2016
May 18, 2016
30643_dirs_2016-05-17_e55f0a3e-d392-462d-bb44-fa1261a51916.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-13
Reporting Person: STAFFIERI MICHAEL DAVID (COO, Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-16 | Common Stock | S | 4934 | $75.6884 | Disposed | 12279 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-13 | Stock Appreciation Rights | $75.42 | A | 66477 | Acquired | 2021-05-13 | Common Stock (66477) | Direct |
Footnotes
F1: Represents the weighted average sale price of $75.6884. The range of prices for the sale of these shares was $75.22 - $75.91, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: This amount includes 330 shares acquired under Issuer's employee stock purchase plan on 12/31/2015.
F3: The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020.